TrialMolecular oncology2014

Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma.

Srikanth R Ambati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.